Clinical Trials Browser

OTHER × SCLC × pembrolizumab × Clear all

NCT04677361 2021-10-08

Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab

Phase EARLY_PHASE1 Withdrawn

SCLC